Physician profile
Sarah Persing
NPI 1003252727
$6,350.10
in general payments reported to CMS, 2019-2025
16 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 75% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $334 · 2022: $355 · 2023: $2,144 · 2024: $2,431 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,916 · Consulting Fee: $500 · Long Term Medical Supply Or Device Loan: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,916.39 |
| Consulting Fee | $500.00 |
| Long Term Medical Supply Or Device Loan | $245.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $2,743.75 | 2023-2025 | Hemoblast Bellows |
| Mentor Worldwide LLC | $994.78 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Molli Surgical (US) INC | $500.00 | 2024 | |
| Aroa Biosurgery Incorporated | $419.63 | 2023-2025 | |
| Biom'Up France Sas | $333.58 | 2021 | |
| Integra Lifesciences Corporation | $280.51 | 2023-2024 | Acell, Integra, Integra Dermal Regeneration Template |
| Axogen | $219.49 | 2023 | Avance Nerve Graft |
| Guard Medical INC. | $185.91 | 2022 | |
| Vector Surgical, LLC | $129.36 | 2022 | |
| Smith+Nephew, INC. | $122.56 | 2022-2023 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Abbvie INC. | $121.42 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $120.66 | 2023 | |
| Kerecis Limited | $79.94 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Polynovo North America LLC | $56.75 | 2023-2024 | Novosorb Btm |
| Avita Medical Americas, LLC | $23.47 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.29 | 2025 | Keytruda, Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Persing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.